Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 1026 - 1050 of 1458 in total
Letaxaban has been used in trials studying the treatment and prevention of Venous Thromboembolism and Acute Coronary Syndrome.
Investigational
CHS-828 has been used in trials studying the treatment of Unspecified Adult Solid Tumor, Protocol Specific.
Investigational
Experimental
Experimental
Tienilic acid, or ticrynafen, is a diuretic drug with uric acid-lowering action which was marketed for the treatment of hypertension. It was withdrawn in 1982 after case reports in the United States suggested a link between ticrynafen and hepatitis. (Manier et al., 1982)
Withdrawn
SNS-314 is a potent and selective inhibitor of Aurora kinases A, B, and C. Proliferating cells treated with SNS-314 bypass the mitotic spindle checkpoint and fail to undergo cytokinesis, leading to multiple rounds of endoreduplication and eventually cell death. SNS-314 inhibits tumor growth in a variety of preclinical models, and...
Investigational
BMS-903452 has been used in trials studying the treatment of Diabetes.
Investigational
LNK 754 has been investigated in Mild Alzheimer's Disease.
Investigational
Quinfamide has been used in trials studying the treatment of Amoebiasis and Helminthiasis.
Investigational
Displaying drugs 1026 - 1050 of 1458 in total